Through two independent validation cohorts, we finally identified five fecal tumor immune-related proteins (CAT, LTF, MMP9, RBP4, and SERPINA3) as well as a biomarker panel that had definite diagnostic value for CRC. This evidence concerns the gene RBP4 and neoplasm.